Integrated Immune Profiling Identifies Treatment-Associated Immune Patterns in Patients with B‑Cell Hematological Malignancies
Integrated serological and cellular profiling provides a scalable framework for characterizing an immune fingerprint with potential prognostic value in patients with B-cell hematological malignancies and supports further investigation of immune monitoring approaches in larger longitudinal cohorts.